- Report
- January 2024
- 113 Pages
Global
From €3500EUR$4,094USD£3,084GBP
- Report
- September 2022
- 274 Pages
Global
From €2289EUR$2,499USD£1,949GBP
€3269EUR$3,570USD£2,784GBP
- Report
- July 2022
- 315 Pages
Global
From €2462EUR$2,688USD£2,096GBP
€3517EUR$3,840USD£2,994GBP
- Report
- February 2022
- 220 Pages
Global
From €2380EUR$2,598USD£2,026GBP
€3400EUR$3,712USD£2,894GBP
- Book
- June 2018
- 368 Pages
- Book
- August 2014
- 240 Pages
- Book
- February 2016
- 384 Pages
- Book
- March 2015
- 432 Pages
- Book
- April 2013
- 320 Pages
- Book
- April 2013
- 584 Pages
- Book
- September 2010
- 418 Pages
- Book
- April 2009
- 528 Pages
- Book
- April 2013
- 778 Pages

The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more